N Katsilambros Selected Research

N Katsilambros Research Topics

Disease

10	Type 2 Diabetes Mellitus (MODY) 03/2018 - 09/2003
4	Glucose Intolerance 06/2014 - 04/2010
3	Insulin Resistance 12/2010 - 04/2009
3	Chronic Kidney Failure (Chronic Renal Failure) 11/2006 - 10/2004
2	Obesity 03/2021 - 04/2010
2	Diabetes Mellitus 12/2007 - 11/2006
2	Infections 02/2006 - 06/2001
2	Renal Insufficiency (Renal Failure) 10/2005 - 10/2004
1	Weight Loss (Weight Reduction) 03/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2011
1	Hyperhomocysteinemia 07/2010
1	Morbid Obesity 04/2010
1	Hyperinsulinism (Hyperinsulinemia) 04/2010
1	Foot Ulcer 03/2009
1	Hyperlipidemias (Hyperlipidemia) 01/2009
1	Papillary Thyroid Cancer 10/2008
1	Nodular Goiter 10/2008
1	Polyneuropathies (Polyneuropathy) 12/2007
1	Acute-Phase Reaction 11/2006
1	Infarction (Infarctions) 11/2006
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2005
1	Unstable Angina 05/2005
1	Myocardial Infarction 05/2005
1	Acute Coronary Syndrome 05/2005
1	Malnutrition (Nutritional Deficiencies) 04/2005
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2004
1	Atherosclerosis 10/2004
1	Inflammation (Inflammations) 03/2004
1	Behcet Syndrome (Behcet's Syndrome) 03/2004
1	Pancreatitis 11/2001
1	Pain (Aches) 11/2001
1	Leukocytosis (Pleocytosis) 11/2001
1	Acute Necrotizing Pancreatitis 11/2001
1	Febrile Neutropenia 06/2001
1	Fever of Unknown Origin 06/2001

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 06/2014 - 04/2009
4	Insulin (Novolin)FDA Link 03/2018 - 05/2005
4	LipidsIBA 12/2010 - 01/2009
2	Triglycerides (Triacylglycerol)IBA 04/2010 - 01/2009
2	Prescription DrugsIBA 10/2009 - 10/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2006 - 06/2001
1	Urokinase Plasminogen Activator ReceptorsIBA 03/2021
1	C-Reactive ProteinIBA 03/2021
1	OsteocalcinIBA 06/2014
1	Methionine (L-Methionine)FDA Link 07/2010
1	BuffersIBA 04/2010
1	Nonesterified Fatty Acids (NEFA)IBA 04/2010
1	LDL CholesterolIBA 04/2009
1	CholesterolIBA 04/2009
1	oxidized low density lipoproteinIBA 04/2009
1	diazonaphthalenedisulfonic acid (NDS)IBA 03/2009
1	Lipoproteins (Lipoprotein)IBA 01/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2009
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2009
1	Fibric Acids (Fibrates)IBA 01/2009
1	Apolipoproteins B (ApoB)IBA 01/2009
1	ParaffinIBA 10/2008
1	Proteins (Proteins, Gene)FDA Link 10/2008
1	EnzymesIBA 10/2008
1	Indicators and Reagents (Reagents)IBA 12/2007
1	Interleukin-6 (Interleukin 6)IBA 11/2006
1	GhrelinIBA 10/2005
1	N 30IBA 05/2005
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2005
1	Metformin (Glucophage)FDA LinkGeneric 05/2005
1	VitaminsIBA 04/2005
1	HomocysteineIBA 04/2005
1	Nateglinide (Starlix)FDA LinkGeneric 02/2005
1	AdiponectinIBA 10/2004
1	Infliximab (Remicade)FDA Link 03/2004
1	repaglinide (Prandin)FDA Link 09/2003
1	Octreotide (Sandostatin)FDA LinkGeneric 11/2001
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2001
1	Amylases FDA Link 11/2001
1	ProcalcitoninIBA 06/2001

Therapy/Procedure

1	Gastrectomy 03/2021
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 03/2021
1	Bariatric Surgery 03/2021
1	Pancreas Transplantation 11/2006
1	Renal Dialysis (Hemodialysis) 10/2004
1	Drug Therapy (Chemotherapy) 06/2001